| abstract |
The present invention provides a sublingual formulation containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The present invention further provides sublingual formulations containing buprenorphine and naloxone, pharmaceutically acceptable salts or derivatives thereof. The present invention further provides a method of treating pain or opioid dependence by administering a sublingual formulation containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof to a patient in need thereof. |